Management of methicillin-resistant Staphylococcus aureus in The Netherlands

    loading  Checking for direct PDF access through Ovid


The Netherlands is one of the countries that is able to keep the prevalence of methicillin-resistant Staphylococcus aureus (MRSA) at a low level. This is the result of a stringent national management policy based on: (1) strict isolation of colonized and infected patients, (2) active search for carriers by screening and treatment of carriership, (3) isolation for a few days of patients transferred to Dutch hospitals from foreign hospitals to allow screening for MRSA. The success of the approach is based on the timely implementation of a national control programme, on the national acceptance of and compliance with the guidelines, and on the traditional Dutch parsimonious use of antimicrobial agents.

Related Topics

    loading  Loading Related Articles